Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
CONCLUSION: A high percentage (49%) of PFO/ASD patients in this series were also migraine sufferers. Percutaneous closure offered migraine relief in 83% of patients, 82% in PFO patients and 89% in ASD patients. Thus, based on this experience and on literature review, a strategic approach for device closure is proposed for migraineurs with a PFO or ASD.
PMID: 28356032 [PubMed - as supplied by publisher]
Source: Reviews on Recent Clinical Trials - Category: Cancer & Oncology Authors: Manolis AS Tags: Rev Recent Clin Trials Source Type: research
More News: Anesthesia | Anesthesiology | Atrial Septal Defect | Cancer & Oncology | Clinical Trials | Headache | Hole in the Heart | Migraine | Patent Foramen Ovale | Stroke | Study